Tampa, Fla. — Among molecularly targeted agents being developed to treat melanoma, some of the most exciting are anti-CTLA-4 antibodies now being developed by Pfizer and Medarex.
Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, and Salivary Biomarkers
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients
What Conferences Are You Planning to Attend in Quarter 1 of 2024?
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium
Skin Cancer Detection With AI: How Intelligent Is It?
POLL: Have Your Patients Asked About Cabtreo for Acne?
2 Clarke Drive Cranbury, NJ 08512